Molecular Pharmaceutics
[ASAP] Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00784
Molecular Pharmaceutics
[ASAP] Voices in Molecular Pharmaceutics: Meet Dr. Anil Jindal, Accomplished Educator and Drug Delivery Technologist
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c00058
Molecular Pharmaceutics
[ASAP] In Vitro and In Vivo Evaluation of Carbopol 71G NF-Based Mucoadhesive Minitablets as a Gastroretentive Dosage Form
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00835
Molecular Pharmaceutics
[ASAP] Controlled Delivery of Vancomycin from Collagen-tethered Peptide Vehicles for the Treatment of Wound Infections
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00898
Molecular Pharmaceutics
[ASAP] Solid-State NMR Characterization of Lyophilized Formulations of Monoclonal Antibody Therapeutics
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00676
Molecular Pharmaceutics
[ASAP] Multifunctional Dendritic Au@SPP@DOX Nanoparticles Integrating Chemotherapy and Low-Dose Radiotherapy for Enhanced Anticancer Activity
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00754
Molecular Pharmaceutics
[ASAP] Safety, Biodistribution, and Dosimetry Study of Meplazumab, a Potential COVID-19 Therapeutic Drug, with <sup>131</sup>I‑Labeling and SPECT Imaging
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00954
Molecular Pharmaceutics
[ASAP] Sublimation of Drugs from the Site of Application of Topical Products
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00816
Molecular Pharmaceutics
[ASAP] Pharmacokinetics and Biodistribution of <sup>89</sup>Zr-Miltuximab and Its Antibody Fragments as Glypican‑1 Targeting Immuno-PET Agents in Glioblastoma
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00760
Molecular Pharmaceutics
[ASAP] Penetration of Vancomycin into Noninfected Bone in Patients Undergoing Total Joint Arthroplasty Evaluated by a Minimal Physiologically Based Population Pharmacokinetic Modeling Approach
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00724